PPT-Targeting EGFR Exon 20 insertions

Author : unita | Published Date : 2024-07-04

Gregory J Riely November 2021 What about those other EGFR mutations EGFR ALK ROS1 BRAF RET MET Exon14 KRAS G12C EGFR exon 20 ERBB2HER2 NTRK Key Subtypes EGFR exon

Presentation Embed Code

Download Presentation

Download Presentation The PPT/PDF document "Targeting EGFR Exon 20 insertions" is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.

Targeting EGFR Exon 20 insertions: Transcript

Gregory J Riely November 2021 What about those other EGFR mutations EGFR ALK ROS1 BRAF RET MET Exon14 KRAS G12C EGFR exon 20 ERBB2HER2 NTRK Key Subtypes EGFR exon 20 insertions 1 of people with NSCLC. X–H insertion reactions based on . carbenoids. Speaker: . Shaolong. Zhang. Supervisor: David . Zhigang. Wang. Date: Jan. . 3. nd. , 2014. 1. Outline. Background. Construction of C-X bond via metal . in the . DMD . gene. Nicolas Wein, PhD. Flanigan Lab. Center for . Gene Therapy. Nationwide Children’s Hospital. Columbus, OH, USA. . Dystrophin. Mutations. Dystrophin gene (Xp21.1) is huge: . 2.4 million nucleotides. Does . the New EPOC trial . eliminate. . Anti. -EGFR antibodies as part of pre-op therapy for curable . liver-only . mCRC. ? . YES!. Cathy Eng, M.D., F.A.C.P.. Associate Professor. Associate Medical Director, Colorectal Center. k. inase . i. nhibition. Danny Rayes . Epidermal Growth Factor Receptor. EGF + EGFR .  growth and proliferation. Mutant EGFR (no ligand) .  growth and proliferation. Inhibiting activating mutations. k. inase . i. nhibition. Danny Rayes . Lung Cancer and Epidermal Growth Factor Receptor. Lung cancer is a leading cause cancer-related death . Two types of lung cancer. Non small cell (NSCLC) 80-85%. (Complete Version). Eric Prebys, FNAL. The Problem. So far, we have talked about a synchrotron made out of identical FODO cells, with the space between the quads taken up by bend dipoles.. The problem is that this is not particularly useful, because there’s no place to put beam in or take it out, and no way to collide beams.. Committee on Ways & Means. Background. May 14, 2013: TIGTA Audit Report, “Inappropriate Criteria Were Used to Identify Tax-Exempt Applications for Review”. Detailed IRS targeting of certain groups based on political beliefs. This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the US, and data that were presented in abstract form. These data should be considered preliminary until published in a peer-reviewed journal.. Growth Factor Receptor (EGFR) mutants and its Clinical Implications. . Jeonghee Cho. Samsung. . Genome Institute. Samsung Medical Center . Outline. Mechanistic insight of . cetuximab. -based EGFR targeted therapy . Cécile Jovelet. Postdocoral. . fellow. Translational. . research. . lab. Gustave Roussy Institute, France. Introduction . 12/04/2017. 2. Lung cancer: . third most frequent cancer. Non-Small Cell Lung Cancer (NSCLC): 80% cases of lung cancer. Cre. 4-OHT. LoxP. LoxP. LoxP. LoxP. Exon 4. Exon 6. Exon . 5. Exon 4. Exon 6. Cre. Exon 4. Exon 6. Exon 4. Exon 6. Exon 4. Exon 4. Exon 4. Exon 4. Exon 6. Allele 1. Allele 2. Allele 1. Allele 2. Exon 5. Prediction. . and. . Data Sorting. Zhengtao. Li/06-24-2019. Introduction. https://www.ppdi.com/About/About-Drug-Discovery-and-Development. What . medchem. should focus?. IP. Target engagement. ADME property. Biodegradable . nanobrushes. for drug delivery. . . Eggehard . Holler, Hui Ding, . Ramachandran Murali, Julia Y. Ljubimova . Cedars-Sinai Medical . Cen. ter. ,. . Los. . Angeles. , U. SA. Drug. in . solid. . tumors. Roberto Bianco. Università degli Studi di Napoli Federico II. robianco@unina.it. c. MET. Receptor Structure. MET is a receptor tyrosine . kinase. MET gene located on chromosome 7 (7q21–q31).

Download Document

Here is the link to download the presentation.
"Targeting EGFR Exon 20 insertions"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.